Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant vs ondansetron for prevention of postoperative nausea and vomiting after strabismus surgery
IRCT20260616069826N1Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative nausea and vomiting (PONV) comparing Aprepitant with Ondansetron (2 arms). Started Jul 2026; status: recruiting.
02
Drugs
aprepitantondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20260616069826N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260616069826N1.